Symposier - ENEA 2010: The cardiotoxicity associated with acromegaly

Links shared publicly online about this topic.

768
total visits

Symposier - ENEA 2010: The cardiotoxicity associated with acromegaly

Uploaded and shared in Youtube by: ecancertv " Dr Christian Berg talks to ecancer.tv about the heightened cardiovascular risk found in acromegaly patients and outlines the factors that contribute to this. Acromegaly patients are more likely to suffer heart disease or myocardial infarction; however, this risk can be reduced using treatments such as pegvisomant. Dr Berg discusses the extent to which this treatment could benefit acromegaly patients and explains how other common symptoms should be a

View full resource at symposier.com

Tags: Heart, Heart Disease, Coronary Artery Disease, Acromegaly, Acromegaly Medication, Disease and Condition, disease